1.
Mult Scler
; : 13524585241242027, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38605496
RESUMEN
Lymphopenia is a known adverse effect in patients with relapsing multiple sclerosis (RMS) treated with fumaric acids. We present a case series of four patients diagnosed with RMS with prolonged lymphocyte stability on dimethyl fumarate for over 1 year who developed significant lymphopenia after transitioning to diroximel fumarate. This case series highlights the need for further research to elucidate the risk of lymphopenia in patients switching between fumaric acids.
2.
JAMA Intern Med
; 183(7): 635-636, 2023 07 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37252717
RESUMEN
This Viewpoint describes programs intended to help patients with commercial insurance that, instead, employers, health plans, and other payers use to reduce their spending on specialty drugs.